Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents

Author： Mei Sheng Duh  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.2, 2008-01, pp. : 99-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

By Escudero-Vilaplana Vicente  

International Journal of Clinical Pharmacy, Vol. 35, Iss. 3, 2013-06 ,pp. : 463-468

Springer Publishing Company

Access to resources Recommend Favorite

Erythropoiesis-Stimulating Agents in Oncology

By Glaspy John A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 6, 2008-07 ,pp. : 565-575

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Differentiating Factors Between Erythropoiesis-Stimulating Agents: A Guide to Selection for Anaemia of Chronic Kidney Disease

By Deicher R.   Hörl W.H.  

Drugs, Vol. 64, Iss. 5, 2004-01 ,pp. : 499-509

Adis International

Access to resources Recommend Favorite

Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE): A Registry for Characterizing Anaemia Management and Outcomes in Oncology Patients

By Larholt Kay  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 159-167

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review

By Wong William B.   Carlson Josh J.   Thariani Rahber   Veenstra David L.  

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1001-1013

Adis International

Access to resources Recommend Favorite